phase 1_2_completion
saveZhejiang Doer Biologics Corp — DR-30206 (Phase I/II Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Adenocarcinoma Of The Gastroesophageal Junction, Colorectal Cancer, Gastrointestinal Tumor, Metastatic Colorectal Cancer